Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,684 studies match

clinicaltrialsPublishedShowing 101–150 of 1,684 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06841354	A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)	recruiting	Phase 3	1,000	Merck Sharp & Dohme LLCINDUSTRY	35	Sep 25, 2026	clinicaltrials
NCT06852222	A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)(cAMeLot-2)	recruiting	Phase 3	600	Janssen Research & Development, LLCINDUSTRY